Last week, the U.S. Food and Drug Administration (FDA) took a significant step towards increased regulation of 503A human drug compounding pharmacies, which may cascade into additional state ...

FDA will convene the Pharmacy Compounding Advisory Committee (PCAC) on July 23-24, 2026, to discuss seven peptides for potential inclusion on the 503A bulks list. An additional five peptides will be ...

As the last year-plus has shown, regulations that seem to make sense in ordinary times can sometimes be revealed to have serious shortcomings during an emergency. In the public health sphere alone, ...

Patients are increasingly exploring treatment options that align with their specific needs and experiences, and 503A ...

Among the local drug compounding regulators for 50 states, Washington, DC, Guam, Puerto and the US Virgin Islands, many say they are working with and appreciate the help of the US Food and Drug ...